Beijing Tsinghua Chang Gung Hospital
🇨🇳China
Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT05225116
- Locations
- 🇨🇳
Beijing Tsinghua Changgung Hospital, Beijing, Beijing, China
Risk Factors and a nOmogram of Venous thromboEmbolism in Patients After liveR Transplantation(ROVER Study)
Completed
- Conditions
- First Posted Date
- 2022-01-26
- Last Posted Date
- 2022-01-26
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 356
- Registration Number
- NCT05209048
- Locations
- 🇨🇳
Beijing Tsinghua Chang Gung Hosipital, Beijing, Beijing, China
Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-11-17
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 66
- Registration Number
- NCT05124002
- Locations
- 🇨🇳
Beijing Tsinghua Chang Gung Hospital, Beijing, Beijing, China
The Biomarker Prediction Model of Septic Risk in Infected Patients
- Conditions
- First Posted Date
- 2021-10-27
- Last Posted Date
- 2021-10-27
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT05095324
- Locations
- 🇨🇳
Tsinghua Changgung Hospital, Beijing, Beijing, China
Venous thromboEmbolism Risk Profiles in Chinese hoSpitalized patiEnts (VERSE Study)
Completed
- Conditions
- First Posted Date
- 2021-09-27
- Last Posted Date
- 2021-09-27
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 27490
- Registration Number
- NCT05058521
- Locations
- 🇨🇳
Beijing Tsinghua Chang Gung Hosipital, Beijing, China
Research on Operating Handle of Colonoscope
- Conditions
- Interventions
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 2
- Registration Number
- NCT04765163
- Locations
- 🇨🇳
Wang Ruigang, Beijing, China
Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-02-04
- Last Posted Date
- 2021-02-04
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 226
- Registration Number
- NCT04738188
- Locations
- 🇨🇳
Beijing Tsinghua Chang Gung Hospital, Beijing, China
MicrOwave and laSer ablaTion Study (MOST Study)
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2021-01-27
- Last Posted Date
- 2022-03-23
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT04726124
- Locations
- 🇨🇳
Beijing Tsinghua Chang Gung Hosipital, Beijing, Beijing, China
CD19/CD20 Dual-CAR-T in B-cell Non-Hodgkin's Lymphoma Patients.
Early Phase 1
Suspended
- Conditions
- Interventions
- First Posted Date
- 2021-01-06
- Last Posted Date
- 2022-02-14
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT04697290
- Locations
- 🇨🇳
Beijing Tsinghua Changgung Hospital, Beijing, Beijing, China
Endovascular thromBectomy of Acute Mesentery Vessels Occlusion Hybrid With Emergent Laparoscopic Surgery
Completed
- Conditions
- First Posted Date
- 2020-12-29
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 42
- Registration Number
- NCT04686981
- Locations
- 🇨🇳
Beijing Tsinghua Chang Gung Hosipital, Beijing, Beijing, China
© Copyright 2024. All Rights Reserved by MedPath